Mitogen activated protein kinases selectively regulate palytoxin- stimulated gene expression in mouse keratinocytes

Toxicology and Applied Pharmacology

Volumn 192, Issue 3, 2003, Pages 212-221

  Zeliadt, Nicholette A ^a   Warmka, Janel K ^a   Wattenberg, Elizabeth V ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

JNK; Keratinocytes; Matrix metalloproteinase 13; Mitogen activated protein kinases; p38; Signal transduction; Tumor promoters

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLLAGENASE 3; DEXAMETHASONE; ENZYME INHIBITOR; GLUCOCORTICOID; MITOGEN ACTIVATED PROTEIN KINASE; PALYTOXIN; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN BINDING;

EID: 0142219793     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00298-9     Document Type: Article

References (60)

1. Airola K., Johansson N., Kariniemi A.L., Kahari V.M., Saarialho-Kere U.K. Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J. Invest. Dermatol. 109:1997;225-231.
2. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
3. Balmain A., Pragnell I.B. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature. 303:1983;72-74.
4. Bergers G., Javaherian K., Lo K.M., Folkman J., Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 284:1999;808-812.
5. Bostrom P.J., Ravanti L., Reunanen N., Aaltonen V., Soderstrom K.O., Kahari V.M., Laato M. Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int. J. Cancer. 88:2000;417-423.
6. Caelles C., Gonzalez-Sancho J.M., Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11:1997;3351-3364.
7. Cavigelli M., Dolfi F., Claret F.X., Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14:1995;5957-5964.
8. Chambers A.F., Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89:1997;1260-1270.
9. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
10. Colandrea T.D., D'Armiento J., Kesari K.V., Chada K.K. Collagenase induction promotes mouse tumorigenesis by two independent pathways. Mol. Carcinogenesis. 29:2000;8-16.
11. D'Armiento J., DiColandrea T., Dalal S.S., Okada Y., Huang M.T., Conney A.H., Chada K. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol. Cell. Biol. 15:1995;5732-5739.
12. English J.M., Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23:2002;40-45.
13. Freije J.M., Diez-Itza I., Balbin M., Sanchez L.M., Blasco R., Tolivia J., Lopez-Otin C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269:1994;16766-16773.
14. Fujiki H., Suganuma M., Nakayasu M., Hakii H., Horiuchi T., Takayama S., Sugimura T. Palytoxin is a non-12-O-tetradecanoylphorbol-13-acetate type tumor promoter in two-stage mouse skin carcinogenesis. Carcinogenesis. 7:1986;707-710.
15. Gille H., Strahl T., Shaw P.E. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 5:1995;1191-1200.
16. Gonzalez M.V., Gonzalez-Sancho J.M., Caelles C., Munoz A., Jimenez B. Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells. FEBS Lett. 459:1999;272-276.
17. +-ATPase. Toxicon. 27:1989;1171-1187.
18. Han Z., Boyle D.L., Chang L., Bennett B., Karin M., Yang L., Manning A.M., Firestein G.S. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108:2001;73-81.
19. Henriet P., Rousseau G.G., Eeckhout Y. Cloning and sequencing of mouse collagenase cDNA. Divergence of mouse and rat collagenases from the other mammalian collagenases. FEBS Lett. 310:1992;175-178.
20. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
21. Jimenez M.J., Balbin M., Alvarez J., Komori T., Bianco P., Holmbeck K., Birkedal-Hansen H., Lopez J.M., Lopez-Otin C. A regulatory cascade involving retinoic acid, Cbfa 1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation. J. Cell Biol. 155:2001;1333-1344.
22. Johansson N., Ala-aho R., Uitto V., Grenman R., Fusenig N.E., Lopez-Otin C., Kahari V.M. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J. Cell Sci. 113:2000;227-235.
23. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone . Cell. 62:1990;1189-1204.
24. Kahari V.M., Saarialho-Kere U. Matrix metalloproteinases in skin. Exp. Dermatol. 6:1997;199-213.
25. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
26. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:1997;240-246.
27. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20:2001;7108-7116.
28. Krane S.M., Byrne M.H., Lemaitre V., Henriet P., Jeffrey J.J., Witter J.P., Liu X., Wu H., Jaenisch R., Eeckhout Y. Different collagenase gene products have different roles in degradation of type I collagen. J. Biol. Chem. 271:1996;28509-28515.
29. Kuroki D.W., Bignami G.S., Wattenberg E.V. Activation of stress-activated protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin. Cancer Res. 56:1996;637-644.
30. Kuroki D.W., Minden A., Sanchez I., Wattenberg E.V. Regulation of a c-Jun amino-terminal kinase/stress-activated protein kinase cascade by a sodium-dependent signal transduction pathway. J. Biol. Chem. 272:1997;23905-23911.
31. Lasa M., Brook M., Saklatvala J., Clark A.R. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell. Biol. 21:2001;771-780.
32. +-ATPase. Toxicol. Appl. Pharmacol. 151:1998;377-384.
33. Li S., Wattenberg E.V. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin. Toxicol. Appl. Pharmacol. 160:1999;109-119.
34. Matrisian L.M. The matrix-degrading metalloproteinases. Bioessays. 14:1992;455-463.
35. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., Brinckerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB differential regulation of collagenase 1 and collagenase 3 . Arthritis Rheum. 43:2000;801-811.
36. Mitev V., Miteva L. Signal transduction in keratinocytes. Exp. Dermatol. 8:1999;96-108.
37. Moore R.E., Bartolini G. Structure of palytoxin. J. Am. Chem. Soc. 103:1981;2491-2494.
38. Mukaida N., Morita M., Ishikawa Y., Rice N., Okamoto S., Kasahara T., Matsushima K. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269:1994;13289-13295.
39. Nagase H., Woessner J.F. Jr. Matrix metalloproteinases. J. Biol. Chem. 274:1999;21491-21494.
40. Onodera S., Nishihira J., Iwabuchi K., Koyama Y., Yoshida K., Tanaka S., Minami A. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J. Biol. Chem. 277:2002;7865-7874.
41. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1996;1247-1255.
42. Ravanti L., Hakkinen L., Larjava H., Saarialho-Kere U., Foschi M., Han J., Kahari V.M. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J. Biol. Chem. 274:1999;37292-37300.
43. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A.R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 78:1994;1027-1037.
44. Rudolph-Owen L.A., Chan R., Muller W.J., Matrisian L.M. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res. 58:1998;5500-5506.
45. Schaeffer H.J., Weber M.J. Mitogen-activated protein kinases specific messages from ubiquitous messengers . Mol. Cell. Biol. 19:1999;2435-2444.
46. Schorpp M., Mattei M.G., Herr I., Gack S., Schaper J., Angel P. Structural organization and chromosomal localization of the mouse collagenase type I gene. Biochem. J. 308:1995;211-217.
47. Schreiber E., Matthias P., Muller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
48. Smeal T., Binetruy B., Mercola D., Grover-Bardwick A., Heidecker G., Rapp U.R., Karin M. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol. Cell. Biol. 12:1992;3507-3513.
49. Smith J.A., Poteet-Smith C.E., Malarkey K., Sturgill T.W. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J. Biol. Chem. 274:1999;2893-2898.
50. Sternlicht M.D., Lochter A., Sympson C.J., Huey B., Rougier J.P., Gray J.W., Pinkel D., Bissell M.J., Werb Z. The stromal proteinase MMP3/ stromelysin-1 promotes mammary carcinogenesis. Cell. 98:1999;137-146.
51. Strickland J.E., Greenhalgh D.A., Koceva-Chyla A., Hennings H., Restrepo C., Balaschak M., Yuspa S.H. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res. 48:1988;165-169.
52. Vu T.H., Werb Z. Matrix metalloproteinases effectors of development and normal physiology . Genes Dev. 14:2000;2123-2133.
53. Warmka J.K., Winston S.E., Zeliadt N.A., Wattenberg E.V. Extracellular signal-regulated kinase transmits palytoxin-stimulated signals leading to altered gene expression in mouse keratinocytes. Toxicol. Appl. Pharmacol. 185:2002;8-17.
54. Wattenberg E.V., Fujiki H., Rosner M.R. Heterologous regulation of the epidermal growth factor receptor by palytoxin, a non-12-O-tetradecanoylphorbol- 13-acetate-type tumor promoter. Cancer Res. 47:1987;4618-4622.
55. Wattenberg E.V., McNeil P.L., Fujiki H., Rosner M.R. Palytoxin down-modulates the epidermal growth factor receptor through a sodium-dependent pathway. J. Biol. Chem. 264:1989;213-219.
56. Whitmarsh A.J., Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:1996;589-607.
57. Whitmarsh A.J., Shore P., Sharrocks A.D., Davis R.J. Integration of MAP kinase signal transduction pathways at the serum response element. Science. 269:1995;403-407.
58. Wilson C.L., Heppner K.J., Labosky P.A., Hogan B.L., Matrisian L.M. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA. 94:1997;1402-1407.
59. Young M.R., Li J.J., Rincon M., Flavell R.A., Sathyanarayana B.K., Hunziker R., Colburn N. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. USA. 96:1999;9827-9832.
60. Zinck R., Cahill M.A., Kracht M., Sachsenmaier C., Hipskind R.A., Nordheim A. Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol. Cell. Biol. 15:1995;4930-4938.